中交地產(000736.SZ):聯合體競得惠州惠城區一宗住宅、商服用地
格隆匯10月24日丨中交地產(000736.SZ)公佈,2019年10月23日,公司收到惠州市國有建設用地使用權電子掛牌交易成交確認書,具體情況如下:
公司與惠州市交融企業管理合夥企業(有限合夥)通過惠州市公共資源交易中心土地與礦業網上掛牌交易系統共同競得惠城區汝湖金石四路南側、規劃編號為JBD62-09、掛牌編號為GP2019-23地塊的國有建設用地使用權,公司在聯合體中的比例為99.5%。該地塊計算指標用地面積為41204.25平方米,宗地使用權面積為31861.86平方米,容積率不大於3,土地用途為住宅、商服用地,土地使用年限為住宅用地70年,商服用地40年。該地塊掛牌成交總價約為7.95億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.